Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: cyclophosphamide|DRUG: epirubicin hydrochloride|DRUG: gemcitabine hydrochloride|DRUG: paclitaxel|GENETIC: comparative genomic hybridization|GENETIC: microarray analysis|GENETIC: mutation analysis|PROCEDURE: conventional surgery|PROCEDURE: neoadjuvant therapy
Sponsor: Cambridge University Hospitals NHS Foundation Trust